Table 1 Demographic characteristics of 278 participants with T2D

Male

167 (60.1)

–

Age in years^a

61.0 ± 9.7

–

Country of birth

14 (5.0)

 Australia

186 (70.5)

 Others^b

78 (29.5)

Healthcare Card Holder^c

132 (49.4)

11 (4.0)

Private Health Insurance Owner

111 (41.6)

11 (4.0)

IRSD Decile^d

4 (1, 6)

–

Education level

11 (4.0)

 Never attended

1 (0.4)

 Primary

18 (6.7)

 Secondary

128 (47.9)

 Trade/TAFE

51 (19.1)

 University diploma/degree

69 (25.8)

Employed

113 (42.3)

11 (4.0)

Smoking Status

12 (4.3)

 Current Smoker

40 (15.0)

BMI (kg/m²)^a

34.0 ± 9.1

2 (0.7)

Diet^d,e

3 (1, 5)

2 (0.7)

Exercise^d,f

5 (3, 7)

2 (0.7)

Number of hypoglycaemic agents used

1 (0.4)

 One agent

5 (1.8)

 Two agents

110 (39.7)

 Three agents

113 (40.8)

 Four or more agents

49 (17.7)

Number of co-morbidities^d

3 (2, 4)

–

Years of Diabetes^a

14.3 ± 7.8

11 (4.0)

 Micro-vascular

161 (57.9)

–

 Macro-vascular

52 (18.7)

–

 Both micro- and macro-vascular complications

38 (13.7)

–

Duration of CGM use (days)^a

12.3 ± 2.5

–

TIR(%)^a

41.6 ± 25.4

–

 %

8.6 (8.0, 9.7)

1 (0.4)

 mmol/mol

70.5 (64.0, 82.5)

1 (0.4)

Intervention study arm

144 (51.8)

–